Post
Artivion presents double win at AATS for aortic devices
Artivion has presented new clinical data from two trials, one demonstrating better patient outcomes when using its On-X aortic valve, …
Merck reports positive results from trial of pneumonia vaccine
German pharmaceutical company Merck KGaA (Merck) has announced positive data from the Phase III STRIDE-10 trial of its investigational pneumococcal …
AIM ImmunoTech reports progress in pancreatic cancer drug trial
US-based biotechnology company AIM ImmunoTech has reported significant progress in its Phase Ib/II DURIPANC trial, which is assessing the combination …
Addex stock tanks after lead drug flops in Phase II epilepsy trial
Addex Therapeutics’s lead drug candidate, developed in collaboration with Johnson and Johnson (J&J), has failed to meet endpoints in a …
Prime Medicine gets green light for trials of first-ever prime editing drug
Prime Medicine has been granted approval by the US Food and Drug Association (FDA) to initiate trials of the first-ever …
AIM ImmunoTech reports progress in pancreatic cancer drug trial
US-based biotechnology company AIM ImmunoTech has reported significant progress in its Phase Ib/II DURIPANC trial, which is assessing the combination …
Addex stock tanks after lead drug flops in Phase II epilepsy trial
Addex Therapeutics’s lead drug candidate, developed in collaboration with Johnson and Johnson (J&J), has failed to meet endpoints in a …
Prime Medicine gets green light for trials of first-ever prime editing drug
Prime Medicine has been granted approval by the US Food and Drug Association (FDA) to initiate trials of the first-ever …
Technoderma begins dosing in atopic dermatitis therapy trial
Chinese biopharmaceutical company Technoderma Medicines has begun dosing patients in its Phase IIa clinical trial of topical TDM-180935 ointment, a …
Cognition Therapeutics finishes enrolment in dementia drug trial
US-based biopharmaceutical company Cognition Therapeutics has finished enrolling subjects in its Phase II SHIMMER study of CT1812 to treat mild-to-moderate …
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate
Bitterroot Bio has dosed the first participants in a Phase I trial investigating its candidate for the treatment of atherosclerotic …
Klineo wins €2m to advance AI patient recruitment platform
Paris-based digital health start-up Klineo has raised €2m ($2.1m) to expand its AI patient recruitment platform to include more types …
Duchenne Muscular Dystrophy: the global clinical trials landscape 2024
Impacting approximately 1 in 5,000 males globally, Duchenne Muscular Dystrophy is a rare genetic disorder characterised by progressive muscle weakness …
Arbele to move ahead with ARB202 gastrointestinal cancer trial
Biotechnology company Arbele has received a positive recommendation from the Data Monitoring Committee (DMC) to continue the Phase I clinical …
Locate Bio raises funding for LDGraft clinical study
UK-based orthobiologics company Locate Bio has secured £9.2m in an oversubscribed funding round, aimed at advancing a clinical study of …